BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15996865)

  • 1. Occult breast cancer presenting as axillary metastases.
    Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
    Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary metastases from occult breast cancer. Our experience.
    Sanguinetti A; Polistena A; D'Ermo G; Lucchini R; Triola R; Conti C; Avenia S; Cavallaro G; De Toma G; Avenia N
    Ann Ital Chir; 2014 Feb; 85(ePub):. PubMed ID: 24576904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Axillary metastases of unknown primary carcinoma].
    Ellend A; Obwegeser R; Auerbach L; Czerwenka K; Kubista E
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):209-13. PubMed ID: 8682287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y
    Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma.
    Ohsie SJ; Moatamed NA; Chang HR; Apple SK
    Ann Diagn Pathol; 2010 Aug; 14(4):260-3. PubMed ID: 20637431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occult breast cancer].
    Vasile D; Palade R; Voiculescu D
    Chirurgia (Bucur); 1998; 93(4):247-53. PubMed ID: 9755574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of occult breast cancer in 44 cases].
    Lu S; Liu H
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
    Zhang Y; Ma QY; Dang CX; Moureau-Zabotto M; Chen WK
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):505-11. PubMed ID: 16257133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of breast cancer metastases and tuberculosis in axillary lymph nodes--a rare association and review of the literature.
    Salemis NS; Razou A
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):608-13. PubMed ID: 20578549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.